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Abstract
Factors that regulate the transfection efficiency of cationic lipid-based carriers are still largely unknown. We have shown
win a previous report F. Liu, H.W. Qi, L. Huang, D. Liu, Factors controlling the efficiency of cationic lipid-mediated
 . xtransfection in vivo via intravenous administration, Gene Ther., 4 1997 517–523. that the transfection efficiency, to the
w  .  .lung, of a lipid formulation composed of N- 1- 2,3-dioleoyloxy propyl-N, N, N-trimethylammonium chloride DOTMA and
Tween 80 is directly proportional to the ratio of DOTMA to DNA. In this study, we investigated the mechanism underlying
the high cationic lipid to DNA ratio dependent transfection activity. Specifically, we have examined the role of free cationic
liposomes in affecting the transfection efficiency of the DNArlipid complexes in vivo by intravenous administration. The
data show that greater transfection activity of DNArlipid complexes in the lung at a higher cationic lipid to DNA ratio is
due to the function of free liposomes present in the DNArlipid mixture. Free liposomes enhance the transfection activity of
DNArlipid complexes by increasing the retention time of DNA and decreasing transgene degradation in different organs. In
 .addition to DOTMA liposomes, liposomes composed of 1,2-dioleoyl-3-trimethylammonium propane chloride DOTAP and
w  X X . x  .3b N- N , N -dimethylaminoethane carbamoyl cholesterol DC-Chol also enhance the level of gene expression in
animals transfected by DNArDOTMA complexes. These results suggest that inclusion of free liposomes into the
DNArlipid complexes may be important in achieving an optimal transfection activity in vivo. q 1998 Elsevier Science
B.V. All rights reserved.
Keywords: Gene therapy; Cationic liposome; Gene transfer; Transfection
1. Introduction
Cationic lipid-based delivery systems have been
w xstudied for their use in gene therapy 1–5 . Of pri-
mary concern for these systems is the gene delivery
efficiency and the underlying mechanisms by which
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the delivery efficiency is determined. The former
often limits the usefulness of the lipid carrier, and the
latter determines the potential for future development.
In the last 10 years, many studies have shown that
lipid-based gene delivery systems are capable of de-
w xlivering genes to cells, both in vitro 6–13 and in
w xvivo 11,13–19 . It is generally believed that transfec-
tion activity of the lipid systems is determined by the
structure formed between the cationic liposomes and
DNA. The formation of such DNArlipid complexes
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is dictated by the structure of the cationic lipid, the
excipients included in the lipid formulation, and the
ratio of the cationic lipid to DNA. Although some
evidences have been presented to support the exis-
wtence of specific DNArlipid complex structures 20–
x22 , the structure–function relationship of the
DNArlipid complexes is yet to be established. More-
over, recent results from our laboratory indicate that,
in addition to the importance of the DNArlipid
structure, free liposomes may play an important role
in determining the transfection activity of the lipid
carrier in vivo following intravenous administration
w x18 .
We have demonstrated that the level of gene ex-
pression in the lung, spleen, heart, liver and kidney
increases with increasing amount of cationic lipid
w xused in formulating the DNA 18 . The ratio of
cationic lipid to DNA resulting in the maximal level
of gene expression was 36:1 cationic lipid:DNAs
.nmol:mg or greater. Theoretical calculation of the
stoichiometry of the cationic lipid to DNA at such
high ratio suggests the possible existence of free lipid
particles in the DNArlipid mixture. It also suggests
that the higher transfection efficiency observed at
high cationic lipid to DNA ratios is caused by the
free lipid particles. The study described in this report
was designed to examine this hypothesis. We provide
direct evidence that free cationic liposomes play im-
portant role in determining the level of gene expres-
sion in vivo. These results are helpful in understand-
ing the mechanisms involved in lipid-based transfec-
tion in vivo and are useful in developing new strate-
gies that will further increase the gene transfer effi-
ciency of lipid-based delivery systems.
2. Materials and methods
2.1. Materials
1,2-Dioleoyl-3-trimethylammonium propane chlo-
 . ride DOTAP was purchased from Avanti Atlanta,
. w  X X .GA, USA . 3b N- N , N -dimethylaminoethane
x  .carbamoyl cholesterol DC-Chol was purchased
 . w from Sigma St. Louis, MO, USA . N- 1- 2,3-di-
.oleoyloxy propyl-N, N, N-trimethylammonium chlo-
 .ride DOTMA was kindly provided by Roche Bio-
 .science Palo Alto, CA, USA . Synthesis and radiola-
beling of diethylenetriaminepentaacetic acid steary-
 .lamide DTPA-SA was performed according to Ka-
w xbalka et al. 23 . A CMV driven expression system
 .containing firefly luciferase cDNA pCMV-Luc was
constructed in the laboratory of Dr. Leaf Huang
Department of Pharmacology, School of Medicine,
.University of Pittsburgh by cloning the genes into
the backbone of a pcDNA3 plasmid Invitrogen,
.Carlsbad, CA, USA . Plasmid DNA was purified by
the method of CsCl-ethidium bromide gradient cen-
w xtrifugation 24 . The purity of the plasmid DNA was
determined by absorbency at 260 and 280 nm and by
1% agarose gel electrophoresis. CD 1 mice male,
.18–20 g were obtained from Charles River,
 .Wilmington, MA, USA .
2.2. Preparation of DNAr lipid complexes
Lipid formulation was prepared as described previ-
w xously 18 . In brief, appropriate amounts of cationic
lipids in chloroform with or without mixing with
Tween 80 in chloroform were placed in a glass tube
and the chloroform was evaporated under a stream of
N gas. The lipid films were vacuum desiccated for a2
minimum of 2 h to remove residual amount of or-
ganic solvent. The dried lipid films were then hy-
 .drated in PBS pH 7.4 at cationic lipid concentration
of 15 mM for 30 min at room temperature. The lipid
suspension was homogenized for 2–3 min using a
Tissue Tearor Biospec Products, Bartlesville, OK,
.  .USA at the maximal speed 20,000 rpm . The aver-
age size of lipid particles as measured by light scat-
tering using a submicron particle analyzer Particle
.Sizing Systems, Santa Barbara, CA, USA was about
200–300 nm. To prepare DNArlipid complexes at
 .6:1 cationic lipid:DNA, nmol:mg , plasmid DNA
 .was first diluted with PBS pH 7.4 to a final concen-
tration of 131.6 mgrml and lipid formulation
w x .DOTMA s15 mM composed of cationic lipid and
Tween 80 in a weight ratio of 6:2 was added drop-
wise to the DNA solution with gentle vortexing. The
final concentration of plasmid DNA in the mixture
was 125 mgrml for all preparations used in this
study. The DNArlipid mixture was kept at room
temperature for about 10 min before being adminis-
tered to the animals.
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2.3. Iodination of plasmid DNA
Iodination of plasmid DNA was performed as
w xdescribed previously 25 . In brief, 2 mCi carrier-free
125  .Na I 5 ml mixed with 10 ml acidifying solution
 .0.075 M HNO , 42-mM sodium acetate, pH 4.73
was added to 22 ml of TE buffer 10-mM Tris–HCl,
.1-mM EDTA, pH 8.0 containing 20 mg of plasmid
 .DNA pCMV-Luc . The mixture was incubated at
 . 608C for 30 min after addition of Tl III ion final
.concentration, 0.27 mM . Five hundred microliters of
TNE buffer 50-mM Tris–HCl, 0.1-M NaCl, 1-mM
.EDTA, pH 7.5 was added and the mixture was
incubated for an additional 30 min. The reaction
mixture, after cooling on ice, was loaded on a pre-
equilibrated Bio-Gel P30 spin column with TE buffer
to remove free 125I. The DNA fraction from the spin
column was dialyzed at 48C against 2=2.5 l of TE
buffer for 24 h to further remove the residual 125I
contamination. 125I-DNA was mixed with cold DNA
of the same construct to the final specific activity of
104 cpmrmg.
2.4. Luciferase acti˝ity assay
Luciferase activity was assayed with a kit pur-
 .chased from Promega Madison, WI, USA using a
luminometer Autolumat LB953, EG & G, Berthhold,
.Germany . Animals were injected through the tail
vein with DNArlipid complexes 25 mg total DNA
.in 200 mlrmouse with or without pre-injection of
free liposomes which were made of cationic lipid
alone without Tween 80. Different organs including
lung, liver, spleen, heart and kidneys were dissected
8 h after the injection of the DNArlipid complexes.
Lysis buffer 0.1-M Tris–HCl, 2-mM EDTA and
.0.1% Triton X-100, pH 7.8 was added at a volume
to weight ratio of 4 mlrmg of the collected organs
except for liver to which 5 ml of lysis bufferrmg of
liver was used. Each organ was homogenized for
 .15–20 s with the tissue tearor ;20,000 rpm to
make a tissue homogenate, which was then cen-
trifuged in a microcentrifuge for 10 min at 12,000
rpm at 48C. A 10-ml aliquot of the supernatant
 .containing about 200-mg total protein was used for
luciferase activity assay. Protein concentration of each
tissue extract was determined by a standard protein
 .assay Bradford reagent from BioRad . Luciferase
activity in each sample was normalized to represent
 .relative light units RLU rmg of extracted protein.
2.5. Tissue distribution
111In-DTPA labeled free liposomes or 125I-labeled
DNArlipid complexes were injected into animals by
tail vein injection. To test the effect of free liposomes
on tissue distribution of DNA in the complexed form
with DOTMArTween 80, each animal received 750
nmol of free DOTMA liposomes in 100 ml 1 min
before the administration of DNArlipid complexes
containing 125I-labeled plasmid DNA. Control ani-
mals received the same volume of PBS for pre-injec-
tion. Animals were sacrificed at different time points
and the amount of radioactivity in each organ was
measured using a Gamma counter. The radioactivity
in the blood was estimated with the assumption that
the total blood in mouse equals 7.4% of total body
w xweight 26 . The blood contamination in each organ
was corrected using a previously described method
w x27 . Results were expressed as percentage of the
total injected doserorgan.
2.6. Southern analysis
Animals pre-injected with either PBS or DOTMA
 .liposomes 750 nmolrmouse in 100 ml were in-
jected with 25 mg of plasmid DNA complexed with
 .DOTMArTween 80 6:2, weight ratio at the cationic
 .lipid to DNA ratio of 6 to 1 nmol: mg . Animals
 .injected with PBS first injection and 25 mg of free
 .plasmid DNA second injection were used as a
control. Animals were sacrificed 30 min after DNA
administration and organs including the lung, spleen,
 .heart, liver about 1r5 of the whole liver and kidney
were collected and immediately frozen on dry ice.
Two-milliliter lysis buffer 10-mM Tris–HCl, 0.1-M
.EDTA, 0.5% SDS, 20 mgrml RNase A, pH 8.0 was
added to each frozen tissue, and the tissue was ho-
mogenized for 20 s and incubated at 378C for 1 h.
Proteinase K was added at a final concentration of
150 mgrml and the tissue homogenate was incubated
for additional 5 h at 608C. Following the extraction
 .with phenol, phenol:chloroform 1:1 and chloroform,
DNA was precipitated with 0.1 volume of 3-M sodium
acetate and 2 volume of ethanol, washed with 70%
ethanol and resuspended in TE buffer. Ten micro-
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grams of DNA from each sample were digested with
10 units of HindIII for 1 h at 378C and then run on a
1.0% agarose gel. DNA bands were transferred to a
 .GeneScreen Plus membrane DuPont NEN overnight
and the membrane was soaked for 2 h at 428C in
prehybridization buffer 50% deionized formamide,
250-mM sodium phosphate, 250-mM NaCl, 1-mM
EDTA, 100 mgrml sonicated salmon sperm DNA
.and 7% SDS . For hybridization, the membrane was
incubated at 428C for 24 h with 32P-labeled probes
recognizing the full luciferase gene of the pCMV-Luc
plasmid. The hybridized bands were visualized in an
X-ray film by autoradiography.
3. Results
3.1. Effect of free liposomes in liposome-mediated
transfection
To test the effect of free liposomes on the transfec-
tion activity of DNArlipid complexes, DNArlipid
Fig. 1. Dose dependent effects of pre-injected free liposomes on
the level of gene expression. DNArlipid complexes containing
25-mg pCMV-Luc plasmid DNA were injected 1 min after the
animals received different amounts of DOTMA liposomes. Lu-
ciferase activity in different tissues was assayed 8 h after the
injection of DNArlipid complexes. Results represent mean"
 . SEM of values obtained from 3–6 mice. I Lung, square filled
. with diagonal zigzag lines spleen, solid square filled with white
.  .  .diagonal dots heart, gray liver and B kidney.
complexes were prepared at a lower cationic lipid to
DNA ratio with our previously used DOTMArTween
 .80 6:2, weight ratio formulation and pCMV-Luc
plasmid. Different amounts of free DOTMA lipo-
somes were intravenously injected into mice 1 min
before the administration of DNArlipid complexes.
 .A 6 to 1 ratio of cationic lipid to DNA nmol:mg
was chosen for the complex preparation because it
 .gives a calculated charge ratio of 2:1 qry which
w xis optimal for transfection in vitro 6–12 . Eight
hours after the administration of DNArlipid com-
plexes, animals were sacrificed and the level of gene
expression was examined in different organs includ-
ing the lung, spleen, heart, liver, and kidney. Fig. 1
shows that, except for spleen, the level of luciferase
activity in all examined organs increased with in-
creasing amount of free DOTMA liposomes pre-in-
jected. For example, the level of luciferase activity in
animals that were pre-injected with 450 nmol of free
DOTMA liposomes was about 100-fold higher than
that in control animals. A dose higher than 450 nmol
did not produce any further increase in the level of
gene expression, suggesting a saturation at 450 nmol
under the experimental conditions.
3.2. Effect of the cationic lipid to DNA ratio in
DNAr lipid complexes
The ratio of cationic lipid to DNA in the
DNArlipid complexes used in the above experiments
 .was 6:1 nmol:mg . To examine whether the potenti-
ating effect of free liposomes was dependent on the
cationic lipid to DNA ratio in the complexes,
DNArlipid complexes were prepared at different
ratios and injected intravenously into animals that
had been pre-injected with different amounts of free
liposomes. In these experiments, the total amount of
cationic liposomes and plasmid DNA each animal
received was the same 25-mg plasmid DNA and 900
.nmol cationic lipid . As shown in Fig. 2, except for
 .DNArlipid complexes at a ratio of 3:1 nmol:mg ,
the ratio of cationic lipid to DNA in the complexes
did not result in any significant difference in the level
of luciferase activity, suggesting that the structure of
DNArlipid complexes formed at either low 6:1,
.  .nmol:mg or high 36:1, nmol:mg cationic lipid to
DNA ratios was equally active. This suggests that the
dominant factor determining the transfection activity
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Fig. 2. Dependence of gene expression on the total cationic lipid
to DNA ratio. DNArlipid complexes with different cationic lipid
to DNA ratios were administered to animals pre-injected with
different amounts of DOTMA liposomes. The total amount of
cationic lipid and plasmid DNA each mouse received was 900
nmol and 25 mg, respectively. Data represent mean"SEM of
values from 3–6 animals. The luciferase activity in each tissue
 .was assayed 8 h post-injection of DNArlipid complexes. I
 . Lung, square filled with diagonal zigzag lines spleen, solid
.  .  .square filled with white diagonal dots heart, gray liver and B
kidney.
of the DNArlipid complexes is the overall amount of
cationic lipid and DNA injected.
3.3. Potentiation acti˝ity of different types of cationic
liposomes
To examine whether the ability of pre-injected free
liposomes for potentiating effect depends on the
structure of cationic lipids, two additional types of
cationic lipids were used. DC-Chol is a cholesterol
derivative with a tertiary amine as the charged head
group. DOTAP has a quaternary amine as the charged
head group that is linked to two hydrophobic fatty
acyl chains by ester bonds. For this purpose, two sets
of experiments were performed. In the first set, ani-
mals were pre-injected with either DC-Chol or
DOTAP liposomes and then injected with plasmid
DNA mixed with DOTMArTween 80 lipid formula-
 .tion DOTMArTween 80s6:2, weight ratio . In the
second set, animals were first injected with free
DOTMA liposomes before injection of plasmid DNA
com plexed with DC-CholrTween 80 or
DOTAPrTween 80 lipid formulation cationic
.lipid:Tween 80s6:2, weight ratio . The total free
liposomes each animal received was 750 nmol and
the amount of DNA in the form of DNArlipid
 .complexes cationic lipid:DNAs6:1, nmol:mg was
25 mgrmouse. As shown in Table 1, the control
animals pre-injected with buffer showed a relatively
low level of luciferase activity for all three types of
DNArlipid complexes. However, in all three cases,
pre-injection of animals with 750 nmol of free lipo-
somes significantly enhanced the level of gene ex-
pression. The greatest increase was obtained in the
lung when animals received free DOTAP liposomes
and DNArDOTMA complexes.
3.4. Time course of free liposome effect
The time course for the effect of free liposomes on
transfection efficiency was determined using DOTMA
Table 1
Potentiating effect of different types of liposomes on the transfection activity of DNArlipid complexesa
y3 .Lipid formulation in DNArlipid complex Pre-injected Luciferase activity RLUrmg=10
 .cationic lipid:DNAs6:1, nmol:mg material
Lung Spleen Heart Liver Kidney
 .DOTMArTween 80 6:2, weight ratio PBS 39.0"3.0 225.6"174.2 52.1"33.3 9.7"6.4 6.7"3.7
bDC-Chol 2586.1"1122.3 131.2"12.5 50.6"9.9 10.1"2.1 2.5"0.6
bDOTAP 9865.3"756.5 964.8"508.1 1261.5"213.7 125.9"36.3 52.4"2.4
 .DOTAPrTween 80 6:2, weight ratio PBS 50.7"25.6 36.5"15.3 0.4"0.1 2.0"0.9 1.1"0.6
bDOTMA 1113.0"149.5 34.3"7.1 22.3"5.6 15.4"2.7 3.2"0.4
 .DC-CholrTween 80 6:2, weight ratio PBS 6.7"4.4 0.5"0.1 0.4"0.1 0.2"0.1 0.3"0.0
bDOTMA 773.1"166.3 13.9"3.2 4.9"0.9 18.9"3.6 3.2"0.6
aEach animal received either PBS or 750 nmol of free liposomes 1 min before being injected with 25-mg plasmid DNA complexed with
different lipid formulations. Data represent mean"SEM of values from 3–6 animals.
bThe cationic lipids injected were in the form of free liposomes.
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liposomes. In these experiments, 750 nmol of
DOTMA liposomes were injected into each animal at
time zero and the DNArlipid complexes
 .DNArDOTMA-Tween 80 were subsequently in-
jected at different times. Results show that the effect
of pre-injection of free liposomes decreased with
 .increasing time between the two injections Fig. 3A .
For example, the luciferase activity in the lung was
approximately 2–5=107 RLUrmg of extracted pro-
tein in animals that were injected with DNArlipid
complexes within 1 h after injection of free lipo-
somes. This activity dropped to a minimum when the
second injection was performed 24 h after administra-
tion of the free liposomes, suggesting a complete loss
of the potentiating activity of the pre-injected free
liposomes.
The effect of post-injection of free liposomes on
transfection activity of DNArlipid complexes was
also examined. Results in Fig. 3B show that post-in-
jection of free liposomes also increased the level of
gene expression. However, the degree of enhance-
ment, compared to pre-injection, was much lower and
shorter in duration. For example, the luciferase activ-
ity obtained from animals which received free lipo-
somes 1 min after receiving the DNArlipid com-
plexes was 2=106 RLUrmg of extracted lung pro-
tein, 40-fold higher than that in the control group, but
15-fold lower than that in animals that received the
same amount of free liposomes 0.5 min prior to
administration of the DNArlipid complexes Fig.
.3A . No increase in transfection efficiency was ob-
served when free liposomes were injected 2 h after
administering the DNArlipid complexes. This indi-
cates that pre-injection is much more effective than
post-injection of free liposomes in enhancing trans-
fection activity of DNArlipid complexes.
3.5. Time dependent tissue distribution of free
DOTMA liposomes
The long lasting effect of pre-injected free lipo-
somes on the level of gene expression prompted us to
study whether the potentiation of gene expression is
directly related to the level of liposome accumulation
in each organ. Table 2 shows the tissue distribution
of DOTMA liposomes as a function of time. Among
the internal organs examined, the lung, blood and
liver are the three major organs that take up most of
the injected liposomes. The amount of liposome in
spleen, heart and kidney was low at less than 3% of
the injected dose within our testing time period. Five
minutes after liposome administration, the highest
level of liposome uptake was observed in the lung
 .49% . Approximately equal level of liposomes were
 .Fig. 3. Time dependent effects of pre-injecting free liposomes on gene expression. Free DOTMA liposomes 750 nmol were injected into
 .  .animals at different times either before A or after B the injection of DNArlipid complexes. Luciferase activity in different tissues was
assayed 8 h post-injection of DNArlipid complexes. The total dose each animal received was 900 nmol for DOTMA and 25 mg for
 .  .  . pCMV-Luc plasmid DNA. Data represent mean"SEM ns3–6 . I Lung, square filled with diagonal zigzag lines spleen, solid
.  .  .square filled with white diagonal dots heart, B liver and B kidney.
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Table 2
Time dependent tissue distribution of free DOTMA liposomesa
 .Time min % Injected dose
bBlood Lung Spleen Heart Liver Kidney Total recovery
5 16.9"1.9 49.3"4.2 1.1"0.2 0.1"0.0 17.4"1.3 1.6"0.1 86.2"3.3
30 16.5"1.9 36.7"4.4 1.1"0.2 0.1"0.0 21.1"2.1 2.4"0.5 77.7"1.8
120 12.6"1.0 4.2"0.4 2.6"0.3 0.1"0.0 53.4"1.2 2.3"0.1 75.0"1.8
720 1.6"0.1 4.4"0.1 2.6"0.2 0.2"0.1 60.6"0.9 2.5"0.3 71.8"1.1
a111In-labeled DOTMA liposomes were injected into mice i.v. at a dose of 750 nmolrmouse. The radioactivity in each organ at specific
 .times was calculated as percentage of total injected. Data represent mean"SEM ns3 .
bTotal recovery represents the sum of the radioactivity from the organs listed.
 .found in the blood and liver ;17% injected dose .
The level of liposome uptake by these organs changed
over time. Levels in the lung and blood decreased
with time while the level in the liver increased. For
example, 12 h post-injection, the amount of lipo-
somes in the lung dropped from the initial 49% to
about 4% of the injected dose, while the amount of
liposomes in liver increased from 17% to about 60%
in the same period. A 10-fold decrease in liposome
 .accumulation in blood from 17% to 1.6% was also
observed.
3.6. Effect of pre-injection of free liposomes on the
tissue distribution of DNAr lipid complexes
Results from our previous study showed that the
level of gene expression in different organs, espe-
cially in the lung, was influenced by the level of
w xDNA binding and retention time 18 . To examine
whether the potentiating effect of free liposomes is
related to an alteration in tissue distribution of DNA
plasmid, a biodistribution study was conducted using
125I-labeled plasmid DNA as a marker. The tissue
distribution of DNA in DNArlipid complexes was
compared between control and test animals that were
pre-injected with either buffer or 750 nmol of free
DOTMA liposomes, respectively. As shown in Fig.
4, the overall tissue distribution of DNA marker
between control and test animals appeared similar at
the earlier time points. Five minutes after injection of
DNArlipid complexes, about 25–30% of injected
dose was found in the lung and approximately 40%
in the liver. Although the level of DNA in the liver
remained about the same level at later time points,
the level of DNA in the lung was 4–5-fold higher in
test animals. These results suggest that free liposomes
increase the retention time of plasmid DNA in the
lung.
3.7. Effect of pre-injection of free liposomes on the
rate of DNA degradation
One of the phenomena observed in our biodistribu-
tion study using 125I-labeled plasmid DNA is that the
Fig. 4. Effects of pre-injecting free liposomes on the tissue
distribution of DNA in DNArlipid complexes. DNArlipid com-
 .plexes cationic lipid:DNA s6:1, nmol:mg containing a trace
amount of 125I-labeled pCMV-Luc plasmid DNA were injected to
animals 1 min after each animal received either PBS or 750 nmol
DOTMA liposomes. The level of 125I radioactivity in each organ
was analyzed at 5, 30, 60 and 120 min post-injection of the
DNArlipid complexes. Open symbols represent the amount of
125I radioactivity in tissues from animals that received PBS.
Filled symbols represent 125I radioactivity in tissues from animals
that received free liposomes before the injection of DNArlipid
 .  .  .complexes. ‘, v Blood, I, B lung, and ^, ’ liver.
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total recovery of 125I count is significantly lower
 . 111data not shown than that of In marker used in
 .liposome studies Table 2 , suggesting that a signifi-
cant level of DNA was degraded after DNA adminis-
tration. To examine the possible role of pre-injected
liposomes in determining the rate of DNA degrada-
tion in different organs, a Southern analysis was
performed in animals with or without pre-injection of
free liposomes. DNA extract from different organs
was prepared and the relative level of transgene in
each sample was analyzed using 32P-labeled full
length luciferase gene as a probe. The rate of DNA
degradation was judged by the size and density of the
DNA band corresponding to the full length luciferase
gene and the size and density of the smear bands with
smaller fragments of the luciferase gene. As shown in
Fig. 5. Effect of pre-injecting free liposomes on DNA degrada-
tion. Southern analysis was performed with DNA extracted from
different organs of animals injected with either free DNA right
.panel or DNArlipid complexes. For animals that received
 .DNArlipid complexes, 750-nmol DOTMA liposomes left panel
 .or PBS buffer middle panel were injected 5 min before the
injection of DNArlipid complexes. DNA extraction was per-
formed 30 min after the DNA administration. Each lane contains
10 mg of total extracted DNA. DNA fragments were probed with
32 P-labeled full length luciferase gene. The positive control far
.left lane used was 150 ng of pCMV-Luc plasmid DNA. The
amount of pCMV-Luc plasmid DNA injected to each mouse was
25 mg.
Fig. 5, transgene degradation occurred in all organs
30 min after DNA administration. Compared to the
 .control group marked as ‘Complex only’ pre-in-
jected with PBS, the DNA band corresponding to the
 .full length plasmid control lane is bigger and denser
in organs from animals marked as ‘Free Liposome
.q Complex’ pre-injected with free liposomes.
Denser bands showing smaller DNA fragments and
longer stretches of the smear bands were also evident
for animals injected with a combination of PBS and
DNArlipid complexes. The same conclusion was
made for other organs, especially the liver. With
exception of a light spot seen in the lane of liver
extract at the bottom of the gel, no DNA bands
stained positive with the same luciferase gene probe
in any tissues of the animals injected with free plas-
mid, suggesting a much faster rate of gene degrada-
tion. These results suggest that cationic liposomes
decrease the rate of gene degradation.
4. Discussion
Cationic lipid-mediated delivery systems have at-
tracted increasing attention as a potential carrier for
gene therapy. One of the major concerns of this
carrier system is its relatively low efficiency com-
w xpared to viral vector systems 1 . Two primary factors
have been shown to affect the transfection efficiency
of lipid carriers; the lipid composition and cationic
lipid to DNA ratio. Although the detailed mechanism
of how lipid composition determines the transfection
activity of DNArlipid complexes is unclear at the
present time, results from our laboratory show that a
higher cationic lipid to DNA ratio in the formulation
increases the transfection activity in vivo by intra-
w xvenous administration 18 . The results, as summa-
rized in this report, suggest that a higher transfection
activity obtained in vivo at a higher cationic lipid to
DNA ratio is largely due to the potentiating activity
 .of free liposomes Figs. 1 and 2 and Table 1 .
While it may still be premature to suggest exactly
how free liposomes enhance the transfection activity
of DNArlipid complexes in different organs, data in
Fig. 4 suggest that the potentiating activity of free
liposomes in transfecting cells in the lung is through
their ability to increase the retention time of DNA
molecules in this organ. Considering the fact that
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cationic liposomes form aggregates when mixed with
blood components such as serum proteins, it is possi-
ble that free liposomes, upon entering the blood
stream, form aggregates with blood components
which are then trapped in the lung endothelial bed.
Theoretically, these liposomes bound to the endothe-
lial cells in lung could significantly slow down the
flow of the DNArlipid complexes through the lung
capillary bed. A slower flow lengthens the exposure
time of DNA to the endothelial cells lining the
vascular wall, resulting in a higher level of gene
expression. An increase in the level of gene expres-
sion resulted from pre-injection of different types of
 .cationic liposomes Table 1 suggests that free lipo-
somes in the lung may enhance transfection effi-
ciency in a non-specific manner and is not dependent
on the specific structure of the cationic lipids. Inter-
estingly, not all types of liposomes that are capable of
being trapped in the lung are able to increase the
retention time of subsequently injected DNArlipid
complexes. For example, we found that multilamellar
 .liposomes d)1 mm composed of PCrCholrPS
 .10:5:1, molar ratio were readily trapped in the lung
at an injected dose of 750 nmolrmouse, the same
liposome dose as that used for cationic liposomes.
Approximately 36% of the injected dose was found
in the lung 5 min after liposome administration,
compared to 29% at 90 min. This level of liposome
uptake did not enhance the retention time of subse-
quently injected DNArDOTMArTween 80 com-
plexes, nor the level of gene expression data not
.shown . Non-cationic liposomes do not seem to po-
tentiate transfection efficiency.
Alternatively, free cationic liposomes could act as
a sensitizer that makes vascular endothelial cells more
transfectable by the DNArlipid complexes. A tissue
distribution study using 111In-DTPA labeled free lipo-
somes showed that these free liposomes stayed in the
lung for a relatively long time. As shown in Table 2,
12 h after the injection of 750 nmol lipidrmouse,
about 4% of the injected dose still remained in the
lung. This level represents a total of 30 nmol of
liposomes in a mouse lung weighing about 150 mg. It
is possible that this level of liposomes in the lung is
sufficient to produce an enhanced level of gene ex-
pression.
Another interesting phenomenon observed in these
experiments was a relatively long residence time of
liposomes in the blood. Two hours post-injection,
approximately 13% of the injected dose was still
circulating in the blood. Such a high blood concentra-
tion is likely due to the high dose injected. It is
unclear whether liposomes in the blood also con-
tribute directly to the potentiating activity of free
liposomes. It is possible that these circulating lipo-
somes may remove inhibitors from blood which oth-
erwise inhibit the transfection activity of DNArlipid
complexes. Result in Fig. 5 suggests that the potenti-
ating effect of free liposomes is through their activity
to decrease the rate of gene degradation. Such activ-
ity is likely the cause for a long lasting effect of
 .pre-injected liposomes Fig. 3 . Additional experi-
ments are needed to elucidate the detailed mecha-
nisms involved.
In summary, the data show that free liposomes
play an important role in affecting the transfection
activity of DNArlipid complexes following intra-
venous injection. Whether an excess amount of
cationic liposomes should be included in the in-
jectable DNA formulations used in many clinical
trials remains to be tested. However, it is possible
that the inclusion of free liposomes into intravenous
DNA formulations may significantly improve trans-
fection activity and result in increased therapeutic
effect.
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